(lp0
S'Derma Sciences to Be Acquired by Integra LifeSciences for $7.00 Per Share of ... Business Wire  - Jan 11, 2017 PRINCETON, N.J.----Derma Sciences, Inc. , a tissue regeneration company focused on advanced wound and burn care, today announced that it has signed a definitive agreement whereby Derma Sciences will be acquired&nbsp;...Integra to Acquire Derma Sciences for $204M - Genetic Engineering & Biotechnology News '
p1
aS'Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for ... GlobeNewswire  - Feb 23, 2017 PLAINSBORO, N.J., Feb. 23, 2017  -- Integra LifeSciences Holdings Corporation  , a global leader in medical technology, announced today that its tender offer by its wholly-owned subsidiary, Integra Derma, Inc.BRIEF-Integra Lifesciences reports acceptance of shares tendered into offer ... - Reuters'
p2
aS'Derma Sciences to Acquire BioD, Solidify Its Leadership Position in Advanced ... Business Wire  - Jul 28, 2016 PRINCETON, N.J.----Derma Sciences, Inc. , a tissue regeneration company focused on advanced wound and burn care, announces the signing of a definitive agreement to acquire BioD, LLC for an immediate transaction&nbsp;...Deal Could Cost Derma Sciences Inc.  $78 Million - Scibility Media$77.8M deal: Princeton tissue regeneration firm buys Tennessee company - Philadelphia Business Journal'
p3
aS"Derma Sciences Hit With Suits Over $204M Integra Buy Law360  - Feb 1, 2017 Law360, New York  -- Integra LifeSciences Holdings Corp.'s proposal to buy Derma Sciences Inc. is unfair to shareholders because it undervalues the company and unfairly rewards Derma Sciences executives, according to&nbsp;..."
p4
aS'Derma Sciences Announces Leadership and CEO Transition Business Wire  - Dec 21, 2015 PRINCETON, N.J.----Derma Sciences, Inc. , a tissue regeneration company focused on advanced wound and burn care, announces that Stephen T. Wills, the Lead Director and a member of the Derma Sciences Board of&nbsp;...'
p5
aS'Derma Sciences Announces Results of Futility Analyses for Phase 3 Clinical ... Business Wire  - Nov 12, 2015 PRINCETON, N.J.----Derma Sciences, Inc. , a tissue regeneration company focused on advanced wound and burn care, announces the termination of its Phase 3 clinical trials with aclerastide  for diabetic foot ulcer&nbsp;...'
p6
aS"Derma Sciences closes $80m deal for BioD Mass Device - Aug 12, 2016 The buyout increased Derma Sciences' sales footprint by more than 300%, adding BioD's 235 independent sales reps and 7 direct reps to it own 63-member team of inside and independent reps."
p7
aS'Form SC 14D9/A DERMA SCIENCES, INC. Filed by: DERMA SCIENCES, INC. StreetInsider.com - Feb 6, 2017 1  amends and supplements the Solicitation/Recommendation Statement on Schedule 14D-9 of Derma Sciences, Inc., a Delaware corporation , filed with the United States Securities and Exchange Commission &nbsp;...'
p8
aS'Derma Sciences Hit With Another Suit Over Integra Buy Law360  - Feb 3, 2017 Law360, New York  -- Another Derma Sciences Inc. shareholder on Friday added his name to the list of proposed class actions filed against the company over Integra LifeSciences Holdings Corp.'
p9
aS'BRIEF-Integra Lifesciences to buy Derma Sciences Reuters - Jan 11, 2017 DUBAI, March 12 Stock markets in the Gulf look set to start the week on a soft footing after crude oil prices plunged at the end of last week to a three-month low, while a likely U.S.'
p10
a.